Epigenica AB has introduced its EpiFinder™ Analysis Service, a fully managed, end-to-end platform designed to deliver fast, reproducible epigenomic data to researchers across academia, pharma, and clinical settings.
ProBioGen, the Berlin-based contract development and manufacturing organisation (CDMO), has introduced CMC Navigator™, a structured framework comprising four defined service models aimed at supporting biopharmaceutical companies through the key stages of protein Chemistry, Manufacturing and Controls (CMC) development.
Carterra Inc. has launched the Vega™ High-Throughput Surface Plasmon Resonance (HT-SPR) instrument, the first 48-channel SPR platform to reach the market. The system is designed to address a long-standing throughput bottleneck in label-free binding analysis, offering a 12-fold increase in throughput compared to the current market-leading system across small and large molecule discovery workflows.
Agilent Technologies has introduced the S540MD Slide Scanner System, a whole slide imaging (WSI) platform designed for high-throughput digital pathology workflows in clinical laboratories.
Biotech Fluidics has introduced the DEGASi® Flat Film in-line degasser, a system that replaces conventional tubular membranes with specialised flat film technology to remove dissolved gases from liquid streams. The design is aimed at instrument developers, manufacturers, and clinical and research laboratories requiring reliable degassing across a broad range of solvents and flow conditions.
Vetter, the Ravensburg-based Contract Development and Manufacturing Organisation (CDMO), has reinforced its sustainability credentials with two significant recognitions: a Platinum rating from the internationally renowned EcoVadis sustainability ranking and official validation of its emission reduction targets by the Science Based Targets initiative (SBTi).
Orikine Bio, the Barcelona-based biotechnology company developing next-generation immunotherapies, has appointed Larry Edwards as Chairman of its Board of Directors, effective 1 January 2026.
Cambridge and Edinburgh-based Axol Bioscience Ltd. has secured $2.8 million (£2.1 million) in new financing and completed a strategic acquisition, marking a significant period of growth for one of the UK’s leading providers of induced pluripotent stem cell (iPSC)-derived technologies for drug discovery and disease research.
Indero, a contract research organisation (CRO) specialising in dermatology and rheumatology, has announced the completion of an internally funded study introducing a novel approach to early-phase evaluation of topical new chemical entities (NCEs). The method applies quantitative gene expression analysis to generate efficacy signals within days rather than the weeks or months typically required by […]
Azenta, Inc. has announced a strategic partnership with UK space biotech company Frontier Space to conduct scientific experiments in microgravity, marking a notable step in the application of clinical-grade sample management technologies beyond Earth.
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.